Starpharma Holdings Insider Confidence Rewarded, Stock Hits AU$166m Market Cap

Simply Wall St.

Jan 30

Insiders who bought Starpharma Holdings Limited (ASX:SPL) stock in the last 12 months were richly rewarded last week. The company's market value increased by AU$21m as a result of the stock's 14% gain...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2607066750"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2607066750\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2607066750?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","is_english":true,"pubTime":"2026-01-30 04:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607066750","market":"nz","top_or_hot":-1,"title":"Starpharma Holdings Insider Confidence Rewarded, Stock Hits AU$166m Market Cap","media":"Simply Wall St.","content":"<div>\n<p>Insiders who bought Starpharma Holdings Limited (ASX:SPL) stock in the last 12 months were richly rewarded last week. The company's market value increased by AU$21m as a result of the stock's 14% gain...</p>\n\n<a href=\"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-insider-confidence-rewarded-stock-hits-a\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starpharma Holdings Insider Confidence Rewarded, Stock Hits AU$166m Market Cap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarpharma Holdings Insider Confidence Rewarded, Stock Hits AU$166m Market Cap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-30 04:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-insider-confidence-rewarded-stock-hits-a><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Insiders who bought Starpharma Holdings Limited (ASX:SPL) stock in the last 12 months were richly rewarded last week. The company's market value increased by AU$21m as a result of the stock's 14% gain...</p>\n\n<a href=\"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-insider-confidence-rewarded-stock-hits-a\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7501","symbol_name":"新冠治疗股","start_time":0,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-insider-confidence-rewarded-stock-hits-a","article_id":"2607066750","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-insider-confidence-rewarded-stock-hits-a","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2607066750","pubTimestamp":1769718512,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Insiders who bought Starpharma Holdings Limited ( ASX:SPL ) stock in the last 12 months were richly rewarded last week...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7501":"新冠治疗股","SPL.AU":"STARPHARMA HOLDINGS LTD","BK7508":"医药生物股","BK7096":"制药"},"translate_title":"Starpharma Holdings内部信心得到回报，股价达到1.66亿澳元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SPL.AU":1},"content_text":"Insiders who bought Starpharma Holdings Limited (ASX:SPL) stock in the last 12 months were richly rewarded last week. The company's market value increased by AU$21m as a result of the stock's 14% gain over the same period.  As a result, the stock they originally bought for AU$126.0k is now worth AU$177.8k.     While insider transactions are not the most important thing when it comes to long-term investing,  logic dictates you should pay some attention to whether insiders are buying or selling shares.  AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.Advertisement The Last 12 Months Of Insider Transactions At Starpharma Holdings   The Independent Non-Executive Chairman Robert Thomas made the biggest insider purchase in the last 12 months. That single transaction was for AU$126k worth of shares at a price of AU$0.28 each.   We do like to see buying, but this purchase was made at well below the current price of AU$0.40.  While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.     You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below.  If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!  See our latest analysis for Starpharma Holdings ASX:SPL Insider Trading Volume January 29th 2026 Starpharma Holdings is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations,  this free list of growing companies with recent insider purchasing, could be just the ticket.   Insider Ownership Of Starpharma Holdings  I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders.  I reckon it's a good sign if insiders own a significant number of shares in the company.   From our data, it seems that Starpharma Holdings insiders own 6.1% of the company, worth about AU$10m.   However, it's possible that insiders might have an indirect interest through a more complex structure.   Whilst better than nothing, we're not overly impressed by these holdings.   So What Does This Data Suggest About Starpharma Holdings Insiders?  It doesn't really mean much that no insider has traded Starpharma Holdings shares in the last quarter.    However, our analysis of transactions over the last year is heartening.   Overall we don't see anything to make us think Starpharma Holdings insiders are doubting the company, and they do own shares.      So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing.    At Simply Wall St, we found 1 warning sign for Starpharma Holdings that deserve your attention before buying any shares.   Of course Starpharma Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}